Published in J Autoimmun on August 04, 2006
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med (2007) 7.73
Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol (2010) 3.69
Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells (2009) 3.01
Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol (2010) 1.70
Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis (2007) 1.49
Regulatory T cells in systemic lupus erythematosus: past, present and future. Arthritis Res Ther (2008) 1.31
Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new. Clin Dev Immunol (2012) 1.27
Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology (2010) 1.10
The pathology of T cells in systemic lupus erythematosus. J Immunol Res (2014) 1.08
Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun (2007) 1.07
Is CD69 an effective brake to control inflammatory diseases? Trends Mol Med (2013) 1.06
CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun Rev (2010) 1.04
Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus. J Immunol (2014) 1.03
Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells. PLoS One (2009) 1.03
Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int (2011) 1.02
CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis. J Clin Immunol (2011) 1.02
Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare. Arthritis Rheumatol (2014) 1.02
Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol (2008) 1.00
Lupus nephritis: an overview of recent findings. Autoimmune Dis (2012) 1.00
Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1. Rheumatology (Oxford) (2008) 0.99
The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients. Clin Rheumatol (2010) 0.99
Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol (2008) 0.98
Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol (2008) 0.96
Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics. Rheumatol Int (2010) 0.95
Future prospects in biologic therapy for systemic lupus erythematosus. Nat Rev Rheumatol (2013) 0.93
Interleukin-21 promotes germinal center reaction by skewing the follicular regulatory T cell to follicular helper T cell balance in autoimmune BXD2 mice. Arthritis Rheumatol (2014) 0.91
Mechanisms of tissue injury in autoimmune liver diseases. Semin Immunopathol (2014) 0.89
Expression and function of dectin-1 is defective in monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol (2012) 0.88
Spontaneous recovery from early glomerular inflammation is associated with resistance to anti-GBM glomerulonephritis: tolerance and autoimmune tissue injury. J Autoimmun (2007) 0.88
Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus. Front Immunol (2015) 0.86
Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun (2016) 0.84
CD4+Foxp3+ T-regulatory cells in noninfectious uveitis. Arch Ophthalmol (2009) 0.83
Expansion of regulatory GITR+CD25 low/-CD4+ T cells in systemic lupus erythematosus patients. Arthritis Res Ther (2014) 0.83
Pathological conditions re-shape physiological Tregs into pathological Tregs. Burns Trauma (2015) 0.83
Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice. Hum Immunol (2008) 0.83
Interleukin-6 promotes systemic lupus erythematosus progression with Treg suppression approach in a murine systemic lupus erythematosus model. Clin Rheumatol (2014) 0.81
Subpopulations of regulatory T cells in rheumatoid arthritis, systemic lupus erythematosus, and Behcet's disease. J Korean Med Sci (2012) 0.81
Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid Arthritis. Arthritis Rheumatol (2016) 0.81
T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus. Cell Immunol (2011) 0.81
Decreased CD127 expression on CD4+ T-cells and elevated frequencies of CD4+CD25+CD127- T-cells in children with long-lasting type 1 diabetes. Clin Dev Immunol (2013) 0.81
Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Dev Immunol (2013) 0.81
Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus. Arthritis Res Ther (2015) 0.80
[Regulatory T‑cells in systemic lupus erythematosus : IL-2 is decisive for loss of tolerance]. Z Rheumatol (2016) 0.80
Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs. Arthritis Res Ther (2009) 0.80
Harnessing regulatory T cells for the treatment of inflammatory bowel disease. Inflamm Bowel Dis (2015) 0.79
T cells in Systemic Lupus Erythematosus. Curr Opin Immunol (2016) 0.78
Lack of association between TESPA1 gene polymorphisms (rs1801876, rs2171497, rs4758994, and rs997173) and ankylosing spondylitis in a Chinese population. Inflammation (2014) 0.77
Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus. J Clin Immunol (2010) 0.77
A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma. PLoS One (2016) 0.76
HDAC expression and activity is upregulated in diseased lupus-prone mice. Int Immunopharmacol (2015) 0.76
Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus. Braz J Med Biol Res (2014) 0.76
CD3(+)CD8(+)CD28(-) T Lymphocytes in Patients with Lupus Nephritis. J Immunol Res (2016) 0.75
CD4(+)CD25(+)CD127(-) and CD4(+)CD25(+)Foxp3(+) Regulatory T Cell Subsets in Mediating Autoimmune Reactivity in Systemic Lupus Erythematosus Patients. Arch Immunol Ther Exp (Warsz) (2016) 0.75
Regulatory CD4+ T-Cell Subsets and Anti-Citrullinated Protein Antibody Repertoire: Potential Biomarkers for Arthritis Development in Seropositive Arthralgia Patients? PLoS One (2016) 0.75
Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients. Arthritis Res Ther (2017) 0.75
Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69(+) T Regulatory Cells. Mediators Inflamm (2017) 0.75
Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice. Clin Exp Med (2014) 0.75
Two separate effects contribute to regulatory T-cell defect in SLE patients and their unaffected relatives. Clin Exp Immunol (2017) 0.75
Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. Ann Intern Med (2006) 5.03
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet (2008) 3.00
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial. Ann Rheum Dis (2011) 2.13
Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis Rheum (2008) 1.73
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum (2012) 1.59
Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab (2009) 1.45
Invasive fungal infections in patients with systemic lupus erythematosus. J Rheumatol (2012) 1.44
Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther (2006) 1.42
Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol (2009) 1.25
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum (2010) 1.24
Molecular cues guiding inflammatory responses. Cardiovasc Res (2010) 1.19
Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol (2010) 1.17
Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab (2006) 1.14
Neuropsychiatric manifestations of systemic lupus erythematosus. J Rheumatol (2013) 1.09
Are steroids required for induction therapy and relapses in lupus nephritis? Ann Rheum Dis (2013) 1.06
Functional role of P-selectin glycoprotein ligand 1/P-selectin interaction in the generation of tolerogenic dendritic cells. J Immunol (2007) 1.04
Correlation between pH and irritant effect of cleansers marketed for dry skin. Int J Dermatol (2002) 1.02
CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis. J Clin Immunol (2011) 1.02
Expression of CD64 as a potential marker of neonatal sepsis. Pediatr Allergy Immunol (2002) 1.02
F-actin-binding protein drebrin regulates CXCR4 recruitment to the immune synapse. J Cell Sci (2010) 1.00
DDT-induced oxidative damage in human blood mononuclear cells. Environ Res (2005) 0.97
Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci U S A (2013) 0.96
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study. Ann Rheum Dis (2012) 0.96
DDT induces DNA damage in blood cells. Studies in vitro and in women chronically exposed to this insecticide. Environ Res (2004) 0.92
Impact of early developmental arsenic exposure on promotor CpG-island methylation of genes involved in neuronal plasticity. Neurochem Int (2011) 0.91
Expression and function of dectin-1 is defective in monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol (2012) 0.88
DDE-induced apoptosis in children exposed to the DDT metabolite. Sci Total Environ (2006) 0.88
Rheumatoid arthritis and the role of oral bacteria. J Oral Microbiol (2010) 0.87
The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors. Endocr Relat Cancer (2010) 0.86
Comparative and prospective study of different immune parameters in healthy subjects at risk for tuberculosis and in tuberculosis patients. Clin Diagn Lab Immunol (2002) 0.85
Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. Hum Immunol (2010) 0.82
IgG4 (IgG4-RD) related diseases, with a horizon not limited to Mikulicz's disease. Reumatol Clin (2013) 0.82
Effect of fluoride exposure on different immune parameters in humans. Immunopharmacol Immunotoxicol (2010) 0.82
Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features. J Clin Endocrinol Metab (2009) 0.82
Analysis of expression and function of the inhibitory receptor ILT2 in lymphocytes from patients with autoimmune thyroid disease. Eur J Endocrinol (2011) 0.81
Effect of pentoxifylline on polarization and migration of human leukocytes. J Leukoc Biol (2002) 0.81
Plasmacytoid dendritic cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab (2013) 0.81
Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Dev Immunol (2013) 0.81
The His155Tyr (489C>T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2X7 receptor in immune cells from patients with rheumatoid arthritis. Cell Immunol (2012) 0.81
DDT induces apoptosis in human mononuclear cells in vitro and is associated with increased apoptosis in exposed children. Environ Res (2004) 0.81
T cell aggregation induced through CD43: intracellular signals and inhibition by the immunomodulatory drug leflunomide. J Leukoc Biol (2003) 0.80
A male patient with cavitary pulmonary disease. Reumatol Clin (2012) 0.79
PKCtheta is required for the activation of human T lymphocytes induced by CD43 engagement. Biochem Biophys Res Commun (2004) 0.79
Rolipram inhibits polarization and migration of human T lymphocytes. J Invest Dermatol (2003) 0.79
[Recommendations for the medical treatment of rheumatoid arthritis]. Rev Invest Clin (2006) 0.79
Pattern of expression of apoptosis and inflammatory genes in humans exposed to arsenic and/or fluoride. Sci Total Environ (2009) 0.79
Defective expression and function of the ILT2/CD85j regulatory receptor in dendritic cells from patients with systemic lupus erythematosus. Hum Immunol (2013) 0.78
[Treatment guidelines for ankylosing spondylitis and its effect on Mexican rheumatology]. Gac Med Mex (2009) 0.78
Effect of polychlorinated biphenyls 118 and 153 on Th1/Th2 cells differentiation. Immunopharmacol Immunotoxicol (2012) 0.78
[Calciphylaxis, renal failure and gout. A patient with hyperuricemia as a risk factor for death]. Rev Med Inst Mex Seguro Soc (2013) 0.78
Abnormal expression and function of Dectin-1 receptor in type 2 diabetes mellitus patients with poor glycemic control (HbA1c>8%). Metabolism (2012) 0.78
[Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE)]. Rev Invest Clin (2009) 0.78
Lack of involvement of P-glycoprotein (P-gp) in pemphigus patients with poor response to steroid therapy. J Dermatol Sci (2002) 0.77
Identification of differential expressed transcripts in cervical cancer of Mexican patients. Tumour Biol (2011) 0.77
Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus. J Clin Immunol (2010) 0.77
Participation of N-methyl-D-aspartate receptors on methylmercury-induced DNA damage in rat frontal cortex. Toxicology (2005) 0.77
Serum cystatin C as a marker of renal function in patients with systemic lupus erythematosus. Reumatol Clin (2012) 0.77
Variability in DDT-induced apoptosis in Mexican indigenous populations. Toxicol Mech Methods (2011) 0.76
Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries? J Rheumatol (2010) 0.76
Hyperglycemia and methylprednisolone: comment on the article by den Uyl et al. Arthritis Rheum (2012) 0.76
Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects. Immunotherapy (2014) 0.76
Prevalence of chronic rheumatic diseases in Mexico. J Rheumatol (2011) 0.75
Severe and unresponsive HIV-associated alopecia areata successfully treated with thalidomide. Acta Derm Venereol (2005) 0.75
Estimating glomerular filtration rate. N Engl J Med (2012) 0.75
[Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis: experience with six pediatric patients. Potential efficacy of methotrexate]. Rev Neurol (2013) 0.75
Concomitant therapy with statins and immunosuppressive agents in childhood primary angiitis of the central nervous system: comment on the article by Cellucci et al. Arthritis Rheum (2012) 0.75
CKD-EPI is the most reliable equation to estimate renal function in patients with systemic lupus erythematosus. Nefrologia (2013) 0.75
p,p'-DDE, a DDT metabolite, induces proinflammatory molecules in human peripheral blood mononuclear cells "in vitro". Exp Toxicol Pathol (2012) 0.75
Tie-2 is overexpressed by monocytes in autoimmune thyroid disorders and participates in their recruitment to the thyroid gland. J Clin Endocrinol Metab (2009) 0.75
Economic impact of estimating renal function in patients with systemic lupus erythematosus. Nefrologia (2012) 0.75
Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman. Rheumatology (Oxford) (2012) 0.75
Laboratory biomarkers for guiding therapy with methotrexate in rheumatoid arthritis. Curr Pharm Des (2015) 0.75
Lupus nephritis: advances in the knowledge of its immunopathogenesis without the expected therapeutic success? Reumatol Clin (2013) 0.75